Autoimmune post-COVID vaccine syndromes: Does the spectrum of autoimmune/inflammatory syndrome expand
Künye
Jara, L. J., Vera-Lastra, O., Mahroum, N., Pineda, C. ve Shoenfeld, Y. (2022). Autoimmune post-COVID vaccine syndromes: Does the spectrum of autoimmune/inflammatory syndrome expand. Clinical Rheumatology, 41(5), 1603-1609. https://doi.org/10.1007/s10067-022-06149-4Özet
To date, around 60% of the world population has been protected by vaccines against SARS-CoV-2, significantly reducing the devastating effect of the pandemic and restoring social economic activity through mass vaccination. Multiple studies have demonstrated the effectiveness and safety of vaccines against COVID-19 in healthy populations, in people with risk factors, in people with or without SARS-CoV-2 infection, and in immunocompromised people. According to the criteria for post-vaccine adverse events established by the World Health Organization, a minority of individuals may develop adverse events, including autoimmune syndromes. The exact mechanisms for the development of these autoimmune syndromes are under study, and to date, a cause-effect relationship has not been established. Many of these autoimmune syndromes meet sufficient criteria for the diagnosis of Adjuvant-Induced Autoimmune Syndrome (ASIA syndrome). The descriptions of these autoimmune syndromes open new perspectives to the knowledge of the complex relationship between the host, its immune system, with the new vaccines and the development of new-onset autoimmune syndromes. Fortunately, most of these autoimmune syndromes are easily controlled with steroids and other immunomodulatory medications and are short-lived. Rheumatologists must be alert to the development of these autoimmune syndromes, and investigate the relationship between autoimmune/inflammatory symptoms and vaccination time, and assess their therapeutic response.
WoS Q Kategorisi
Q3Scopus Q Kategorisi
Q1Kaynak
Clinical RheumatologyCilt
41Sayı
5Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
The 13th international. congress on autoimmunity 2022 (AUTO13) Athens: An event as big as the topics
Etsatti, Abdutrahman; Atwani, Abdutkarim; Seida, İsa; Atrais, Mahmoud; Seida, Ravend; Esirgun, Sevvat Nit; Abalı, Tunahan; Kıyak, Zeynep; Mahroum, Naim (Israel Medical Association Journal, 2022)The gathering of the 13th International Congress on Autoimmunity 2022 (AUTO13) could not have been held at a place better than the beautiful city of Athens, Greece, at the Megaron Athens International Conference Center ... -
Corrigendum to “The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual” [Autoimmunity Reviews, Volume 20 (2021) 102945]
Mahroum, Naim; Damoiseaux, Jan; Zoubi, Magdi; Lavine, Noy; Ohayon, Aviran; Amital, Howard; Shoenfeld, Yehuda (Elsevier, 2022)... -
Herpes simplex virus and SLE: Though uncommon yet with significant implications
Mahroum, Naim; Elsalti, Abdulrahman; Shoenfeld, Yehuda (NLM (Medline), 2023)To the Editor,The relation between infectious agents, particularly viruses, withautoimmunity and autoimmune diseases, has been extensivelystudied during the last decades. Recently, the association was shownto be even ...